Cargando…
Assessment of bone response to systemic therapy in an EORTC trial: preliminary experience with the use of collagen cross-link excretion
This study was designed to evaluate new bone resorption and tumour markers as possible alternatives to serial plain radiographs for the assessment of response to treatment. Thirty-seven patients with newly diagnosed bone metastases from breast cancer, randomized to receive oral pamidronate or placeb...
Autores principales: | Vinholes, J, Coleman, R, Lacombe, D, Rose, C, Tubiana-Hulin, M, Bastit, P, Wildiers, J, Michel, J, Leonard, R, Nortier, J, Mignolet, F, Ford, J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362989/ https://www.ncbi.nlm.nih.gov/pubmed/10390000 http://dx.doi.org/10.1038/sj.bjc.6690506 |
Ejemplares similares
-
Preliminary results of the use of urinary excretion of pyridinium crosslinks for monitoring metastatic bone disease.
por: Coleman, R. E., et al.
Publicado: (1992) -
Comparative genomic hybridization detects many recurrent imbalances in central nervous system primitive neuroectodermal tumours in children
por: Avet-Loiseau, H, et al.
Publicado: (1999) -
Relevance of hydroxyproline excretion to bone metastasis in breast cancer.
por: Gielen, F., et al.
Publicado: (1976) -
Collagen crosslink excretion and staging of oral cancer
por: Springer, I N G, et al.
Publicado: (2003) -
Measurement of urinary collagen cross-links indicate response to therapy in patients with breast cancer and bone metastases
por: Walls, J, et al.
Publicado: (1999)